EPFL Investor Day 2024

10 Dec 2024 | Lausanne, Switzerland

Gian Luca Barbruni

CEO

MoleSense

Neuchâtel, Switzerland

36 profile visitsSpeaker

Every woman deserves personalized care that is tailored to her biology and age. Our molecular wearables are the solution.

My organisation

MoleSense

MoleSense

Startup in Creation

Neuchâtel, Switzerland

At MoleSense, we are redefining women's healthcare with our ‘molecular wearables,’ a new class of medical devices that not only track biophysical and physiological biomarkers such as body temperature and heart rate but also continuously monitor chemical biomarkers like metabolites, electrolytes, proteins, and hormones that, until now, have only been measured sporadically through traditional blood tests. Our mission is to empower women with actionable insights into their reproductive health, from preconception to menopause through motherhood.
Read more

About me

Gian Luca received his Ph.D. in Microelectronics and Microsystems from EPFL. He has a 5-year of experience in bioelectronics and 7-year of experience in Italian real estate. Graduated from the Business Creation in Medtech, he is a highly motivated entrepreneur. His mission is to exploit cutting-edge technology to advance female healthcare.

My organisation

MoleSense

At MoleSense, we are redefining women's healthcare with our ‘molecular wearables,’ a new class of medical devices that not only track biophysical and physiological biomarkers such as body temperature and heart rate but also continuously monitor chemical biomarkers like metabolites, electrolytes, proteins, and hormones that, until now, have only been measured sporadically through traditional blood tests. Our mission is to empower women with actionable insights into their reproductive health, from preconception to menopause through motherhood.

Social media

Speaker sessions (1)

Tuesday, 10 December 2024

17:30 - 18:00

Pitch Session Startups in creation

Format:In-personLocation:Pitch Area 1Track:Pitch Session

The final pitch session will spotlight startups in the creation phase, offering a sneak peek at the next wave of market-disrupting innovations.